Cargando…

Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis

PURPOSE: Type 1 diabetes mellitus (T1DM) is a chronic and immune-mediated disease, which is characterized by the progressive destruction of pancreatic beta cells. T1DM precipitates in genetically susceptible individuals through environmental factors. In this study, we aimed to evaluate the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gürsoy, Semra, Koçkar, Tuba, Atik, Sezen Ugan, Önal, Zerrin, Önal, Hasan, Adal, Erdal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Pediatric Society 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106689/
https://www.ncbi.nlm.nih.gov/pubmed/30032588
http://dx.doi.org/10.3345/kjp.2018.61.7.217
_version_ 1783349826321121280
author Gürsoy, Semra
Koçkar, Tuba
Atik, Sezen Ugan
Önal, Zerrin
Önal, Hasan
Adal, Erdal
author_facet Gürsoy, Semra
Koçkar, Tuba
Atik, Sezen Ugan
Önal, Zerrin
Önal, Hasan
Adal, Erdal
author_sort Gürsoy, Semra
collection PubMed
description PURPOSE: Type 1 diabetes mellitus (T1DM) is a chronic and immune-mediated disease, which is characterized by the progressive destruction of pancreatic beta cells. T1DM precipitates in genetically susceptible individuals through environmental factors. In this study, we aimed to evaluate the impact of autoimmunity and intestinal colonization of Candida albicans on the development of T1DM. METHODS: Forty-two patients newly diagnosed with T1DM and 42 healthy subjects were included in this monocentric study. The basic and clinical characteristics of the patients were recorded. T1DM-, thyroid-, and celiac-associated antibodies were evaluated. Stool cultures for C. albicans were performed to assess whether or not gut integrity was impaired in patients with T1DM. RESULTS: The evaluation of T1DM- and thyroid-associated antibodies showed that the prevalences of islet cell antibodies and antithyroperoxidase positivity were higher in the study patients than in the patients in the control group. Furthermore, the direct examination and culture of fresh stool samples revealed that 50% of the patients with T1DM and 23.8% of the control subjects had fungi (C. albicans). CONCLUSION: Through this study, we suggest that the presence of intestinal C. albicans colonization at the time of the diagnosis of T1DM may indicate impairment of normal intestinal microbiota. We also suggest that there may be a tendency of T1DM in patients with a high prevalence of intestinal C. albicans.
format Online
Article
Text
id pubmed-6106689
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Korean Pediatric Society
record_format MEDLINE/PubMed
spelling pubmed-61066892018-08-29 Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis Gürsoy, Semra Koçkar, Tuba Atik, Sezen Ugan Önal, Zerrin Önal, Hasan Adal, Erdal Korean J Pediatr Original Article PURPOSE: Type 1 diabetes mellitus (T1DM) is a chronic and immune-mediated disease, which is characterized by the progressive destruction of pancreatic beta cells. T1DM precipitates in genetically susceptible individuals through environmental factors. In this study, we aimed to evaluate the impact of autoimmunity and intestinal colonization of Candida albicans on the development of T1DM. METHODS: Forty-two patients newly diagnosed with T1DM and 42 healthy subjects were included in this monocentric study. The basic and clinical characteristics of the patients were recorded. T1DM-, thyroid-, and celiac-associated antibodies were evaluated. Stool cultures for C. albicans were performed to assess whether or not gut integrity was impaired in patients with T1DM. RESULTS: The evaluation of T1DM- and thyroid-associated antibodies showed that the prevalences of islet cell antibodies and antithyroperoxidase positivity were higher in the study patients than in the patients in the control group. Furthermore, the direct examination and culture of fresh stool samples revealed that 50% of the patients with T1DM and 23.8% of the control subjects had fungi (C. albicans). CONCLUSION: Through this study, we suggest that the presence of intestinal C. albicans colonization at the time of the diagnosis of T1DM may indicate impairment of normal intestinal microbiota. We also suggest that there may be a tendency of T1DM in patients with a high prevalence of intestinal C. albicans. Korean Pediatric Society 2018-07 2018-07-15 /pmc/articles/PMC6106689/ /pubmed/30032588 http://dx.doi.org/10.3345/kjp.2018.61.7.217 Text en Copyright © 2018 by The Korean Pediatric Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Gürsoy, Semra
Koçkar, Tuba
Atik, Sezen Ugan
Önal, Zerrin
Önal, Hasan
Adal, Erdal
Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis
title Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis
title_full Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis
title_fullStr Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis
title_full_unstemmed Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis
title_short Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis
title_sort autoimmunity and intestinal colonization by candida albicans in patients with type 1 diabetes at the time of the diagnosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106689/
https://www.ncbi.nlm.nih.gov/pubmed/30032588
http://dx.doi.org/10.3345/kjp.2018.61.7.217
work_keys_str_mv AT gursoysemra autoimmunityandintestinalcolonizationbycandidaalbicansinpatientswithtype1diabetesatthetimeofthediagnosis
AT kockartuba autoimmunityandintestinalcolonizationbycandidaalbicansinpatientswithtype1diabetesatthetimeofthediagnosis
AT atiksezenugan autoimmunityandintestinalcolonizationbycandidaalbicansinpatientswithtype1diabetesatthetimeofthediagnosis
AT onalzerrin autoimmunityandintestinalcolonizationbycandidaalbicansinpatientswithtype1diabetesatthetimeofthediagnosis
AT onalhasan autoimmunityandintestinalcolonizationbycandidaalbicansinpatientswithtype1diabetesatthetimeofthediagnosis
AT adalerdal autoimmunityandintestinalcolonizationbycandidaalbicansinpatientswithtype1diabetesatthetimeofthediagnosis